Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable powder for intravenous use. It is employed to treat severe bacterial infections such as intra‑abdominal infections, urinary tract infections, pneumonia, meningitis, and sepsis in adult patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved batches to acute care facilities, ensuring consistent quality and reliable delivery across global markets. Clients benefit from GNH USA's robust cold‑chain logistics and compliance with international pharmacopeial standards.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

Complicated intra‑abdominal infections: achieves rapid bactericidal activity to resolve severe intra‑abdominal sepsis and reduce mortality. Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens causing pyelonephritis and cystitis, including ESBL‑producing strains. Nosocomial pneumonia: provides effective coverage against multidrug‑resistant organisms in hospital‑acquired lung infections, including Pseudomonas aeruginosa. Meningitis: penetrates the cerebrospinal fluid to eradicate bacterial meningitis pathogens and prevent neurological complications. Severe sepsis: delivers broad‑spectrum killing to control systemic infection and organ dysfunction while supporting organ function.